Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2014: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Outline of Final Research Achievements |
The purposes of this study were to establish the method of evaluating aging process in human hematopoietic stem cells (HSC) and to detect biological variations of HSC induced by HSC transplantation. We analyzed aging process of HSC with the use of CD34-positive cell population as a substitute for a single HSC. As a result, the ratio of Ikaros/CEPBPa, which are transcription factors of lymphoid and myeloid respectively of primitive HSC, can be used as an evaluation method for HSC variation at the age of between 15 and 45. Although the precision of this method should be improved with some modifications, aging process by HSC transplantation can be shown with this method.
|